Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


16.10.2017

1 Biomed Pharmacother
1 BJU Int
1 Br J Nutr
1 Cell
1 Curr Cancer Drug Targets
1 Dermatol Online J
1 Eur J Radiol
1 Indian J Urol
1 Int J Clin Oncol
1 J Biophotonics
1 J Gene Med
1 Mol Med Rep
3 Nat Rev Urol
1 Radiother Oncol
1 Urol Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biomed Pharmacother

  1. WU X, Yan T, Wang Z, Wu X, et al
    LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b.
    Biomed Pharmacother. 2017;96:299-304.
    PubMed     Text format     Abstract available


    BJU Int

  2. SMITH AB, Jaeger B, Pinheiro LC, Edwards LJ, et al
    The impact of bladder cancer on health-related quality of life.
    BJU Int. 2017 Oct 8. doi: 10.1111/bju.14047.
    PubMed     Text format     Abstract available


    Br J Nutr

  3. AUGUSTIN LSA, Taborelli M, Montella M, Libra M, et al
    Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control study.
    Br J Nutr. 2017 Oct 9:1-8. doi: 10.1017/S0007114517002574.
    PubMed     Text format     Abstract available


    Cell

  4. ROBERTSON AG, Kim J, Al-Ahmadie H, Bellmunt J, et al
    Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
    Cell. 2017 Oct 4. pii: S0092-8674(17)31056-5. doi: 10.1016/j.cell.2017.
    PubMed     Text format     Abstract available


    Curr Cancer Drug Targets

  5. FEDERICO A, Zappavigna S, Dallio M, Misso G, et al
    Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.
    Curr Cancer Drug Targets. 2017;17:109-121.
    PubMed     Text format     Abstract available


    Dermatol Online J

  6. CALLAHAN S, Kim RH, Brinster N, Latkowski JA, et al
    Kaposi's sarcoma in an HIV-negative patient.
    Dermatol Online J. 2016;22.
    PubMed     Text format     Abstract available


    Eur J Radiol

  7. WOO S, Suh CH, Kim SY, Cho JY, et al
    Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis.
    Eur J Radiol. 2017;95:46-55.
    PubMed     Text format     Abstract available


    Indian J Urol

  8. MITASH N, Agnihotri S, Tiwari S, Agrawal V, et al
    MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer.
    Indian J Urol. 2017;33:283-290.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  9. NAZARI A, Khorramdelazad H, Hassanshahi G
    Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Int J Clin Oncol. 2017 Oct 11. doi: 10.1007/s10147-017-1187.
    PubMed     Text format     Abstract available


    J Biophotonics

  10. NGUYEN VP, Oh J, Park S, Wook Kang H, et al
    Feasibility of photoacoustic evaluations on dual-thermal treatment of ex vivo bladder tumors.
    J Biophotonics. 2017;10:577-588.
    PubMed     Text format     Abstract available


    J Gene Med

  11. FANG Y, Wolfson B, Godbey WT
    Non-invasive Detection of Bladder Cancer via Expression-targeted Gene Delivery.
    J Gene Med. 2017 Oct 11. doi: 10.1002/jgm.2992.
    PubMed     Text format     Abstract available


    Mol Med Rep

  12. CHEN L, Yuan L, Wang G, Cao R, et al
    Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.
    Mol Med Rep. 2017 Oct 4. doi: 10.3892/mmr.2017.7726.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  13. STONE L
    Bladder cancer: Mastering the immune microenvironment.
    Nat Rev Urol. 2017 Oct 10. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  14. THOMA C
    Bladder cancer: Benefit of adjuvant chemotherapy in UTUC unclear.
    Nat Rev Urol. 2017 Oct 10. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  15. THOMA C
    Bladder cancer: Combination therapy effective in advanced disease.
    Nat Rev Urol. 2017 Oct 10. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Radiother Oncol

  16. PIETERS BR, van der Steen-Banasik E, Smits GA, De Brabandere M, et al
    GEC-ESTRO/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma.
    Radiother Oncol. 2017;122:340-346.
    PubMed     Text format     Abstract available


    Urol Oncol

  17. AHAMAD A, Martinez A, Salenius S, Ross R, et al
    Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers.
    Urol Oncol. 2017 Oct 6. pii: S1078-1439(17)30473.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: